Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Päätekijät: Xiang Tong (Tekijä), Shijie Zhang (Tekijä), Dongguang Wang (Tekijä), Li Zhang (Tekijä), Jizheng Huang (Tekijä), Tianli Zhang (Tekijä), Hong Fan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...